Standard BioTools Inc.

Contributing Author

Recent Articles by Standard BioTools Inc.

Oct-05	Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED LAB LAB -5.37% GlobeNewswire
Sep-30	Standard BioTools Provides Update on Sale of Mass Cytometry Business LAB GlobeNewswire
Aug-05	Standard BioTools Reports Second Quarter 2026 Financial Results LAB GlobeNewswire
Jul-28	Standard BioTools Announces Sale of Mass Cytometry Business and Illumina's Buyout of Contingent Payments to Advance Merger with Treeline Biosciences LAB GlobeNewswire
Jul-22	Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026 LAB -7.43% GlobeNewswire
Jul-20	Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction LAB -5.02% GlobeNewswire
Jun-08	Standard BioTools and Treeline Biosciences Announce Merger Agreement LAB -30.16% GlobeNewswire
May-05	Standard BioTools Reports First Quarter 2026 Financial Results LAB GlobeNewswire
Apr-21	Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026 LAB GlobeNewswire
Feb-24	Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results LAB GlobeNewswire
Feb-10	Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 LAB GlobeNewswire
Jan-30	Standard BioTools Completes Sale of SomaLogic to Illumina LAB GlobeNewswire
Jan-08	Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue LAB +20.31% GlobeNewswire
Nov-04	Standard BioTools Reports Third Quarter 2025 Financial Results LAB GlobeNewswire
Oct-21	Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025 LAB GlobeNewswire
Aug-11	Standard BioTools Reports Second Quarter 2025 Financial Results LAB GlobeNewswire
Aug-06	Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study LAB GlobeNewswire
Jul-21	Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025 LAB GlobeNewswire
Jun-23	Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina LAB +17.14% GlobeNewswire
May-30	Standard BioTools to Host Inaugural "Proteomics Roundtable" Webcast Series LAB GlobeNewswire
May-06	Standard BioTools Reports First Quarter 2025 Financial Results LAB -7.83% GlobeNewswire

Standard BioTools Inc.

Recent Articles by Standard BioTools Inc.

Upgrade your Finviz experience